The polarity protein Scrib limits atherosclerosis development in mice.


Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
01 Dec 2019
Historique:
received: 26 09 2018
revised: 27 02 2019
accepted: 02 04 2019
pubmed: 6 4 2019
medline: 7 7 2020
entrez: 6 4 2019
Statut: ppublish

Résumé

The protein Scrib (Scribble 1) is known to control apico-basal polarity in epithelial cells. The role of polarity proteins in the vascular system remains poorly characterized; however, we previously reported that Scrib maintains the endothelial phenotype and directed migration. On this basis, we hypothesized that Scrib has anti-atherosclerotic functions. Tamoxifen-induced Scrib-knockout mice were crossed with ApoE-/- knockout mice and spontaneous atherosclerosis under high-fat diet (HFD), as well as accelerated atherosclerosis in response to partial carotid artery ligation and HFD, was induced. Deletion of Scrib resulted in increased atherosclerosis development in both models. Mechanistically, flow- as well as acetylcholine-induced endothelium-dependent relaxation and AKT phosphorylation was reduced by deletion of Scrib, whereas vascular permeability and leucocyte extravasation were increased after Scrib knockout. Scrib immune pull down in primary carotid endothelial cells and mass spectrometry identified Arhgef7 (Rho Guanine Nucleotide Exchange Factor 7, βPix) as interaction partner. Scrib or Arhgef7 down-regulation by siRNA reduced the endothelial barrier function in human umbilical vein endothelial cells. Gene expression analysis from murine samples and from human biobank material of carotid endarterectomies indicated that loss of Scrib resulted in endothelial dedifferentiation with a decreased expression of endothelial signature genes. By maintaining a quiescent endothelial phenotype, the polarity protein Scrib elicits anti-atherosclerotic functions.

Identifiants

pubmed: 30949676
pii: 5428147
doi: 10.1093/cvr/cvz093
doi:

Substances chimiques

ARHGEF7 protein, human 0
Arhgef7 protein, mouse 0
Intracellular Signaling Peptides and Proteins 0
Membrane Proteins 0
Rho Guanine Nucleotide Exchange Factors 0
SCRIB protein, human 0
Tumor Suppressor Proteins 0
scribble protein, mouse 0
Proto-Oncogene Proteins c-akt EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1963-1974

Commentaires et corrections

Type : CommentIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

Christoph Schürmann (C)

Institute for Cardiovascular Physiology, Goethe-University, Theodor-Stern Kai 7, Frankfurt, Frankfurt am Main, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor-Stern Kai 7, Frankfurt, Germany.

Franziska L Dienst (FL)

Institute for Cardiovascular Physiology, Goethe-University, Theodor-Stern Kai 7, Frankfurt, Frankfurt am Main, Germany.

Katalin Pálfi (K)

Institute for Cardiovascular Physiology, Goethe-University, Theodor-Stern Kai 7, Frankfurt, Frankfurt am Main, Germany.

Andrea E Vasconez (AE)

Institute for Cardiovascular Physiology, Goethe-University, Theodor-Stern Kai 7, Frankfurt, Frankfurt am Main, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor-Stern Kai 7, Frankfurt, Germany.

James A Oo (JA)

Institute for Cardiovascular Physiology, Goethe-University, Theodor-Stern Kai 7, Frankfurt, Frankfurt am Main, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor-Stern Kai 7, Frankfurt, Germany.

ShengPeng Wang (S)

Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Ludwigstrasse 43, Bad Nauheim, Germany.

Giulia K Buchmann (GK)

Institute for Cardiovascular Physiology, Goethe-University, Theodor-Stern Kai 7, Frankfurt, Frankfurt am Main, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor-Stern Kai 7, Frankfurt, Germany.

Stefan Offermanns (S)

German Center for Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor-Stern Kai 7, Frankfurt, Germany.
Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Ludwigstrasse 43, Bad Nauheim, Germany.

Bart van de Sluis (B)

Department of Pediatrics, Molecular Genetics Section, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 1, AV Groningen, The Netherlands.

Matthias S Leisegang (MS)

Institute for Cardiovascular Physiology, Goethe-University, Theodor-Stern Kai 7, Frankfurt, Frankfurt am Main, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor-Stern Kai 7, Frankfurt, Germany.

Stefan Günther (S)

ECCPS Bioinformatics and Sequencing Facility, Goethe-University, Ludwigstrasse 43, Bad Nauheim, Germany.

Patrick O Humbert (PO)

Department of Biochemistry & Genetics, La Trobe Institute for Molecular Science, La Trobe University, Kingsbury Drive, Melbourne, Victoria, Australia.
Department of Clinical Pathology, Department of Molecular Biology and Biochemistry, The University of Melbourne, Grattan Street, Parkville, Victoria, Australia.

Eunjee Lee (E)

Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY, USA.
Sema4 Genomics, a Mount Sinai Venture, 333 Ludlow Street, South tower 3rd floor, Stamford, CT, USA.

Jun Zhu (J)

Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY, USA.
Sema4 Genomics, a Mount Sinai Venture, 333 Ludlow Street, South tower 3rd floor, Stamford, CT, USA.

Andreas Weigert (A)

Institute of Biochemistry I-Pathobiochemistry, Goethe-University, Frankfurt, Theodor-Stern Kai 7, Frankfurt am Main, Germany.

Praveen Mathoor (P)

Institute of Biochemistry I-Pathobiochemistry, Goethe-University, Frankfurt, Theodor-Stern Kai 7, Frankfurt am Main, Germany.

Ilka Wittig (I)

German Center for Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor-Stern Kai 7, Frankfurt, Germany.
Functional Proteomics, SFB815 Core Unit, Medical School, Goethe University, Frankfurt, Theodor-Stern Kai 7, Frankfurt am Main, Germany.

Christoph Kruse (C)

Institute for Cardiovascular Physiology, Goethe-University, Theodor-Stern Kai 7, Frankfurt, Frankfurt am Main, Germany.

Ralf P Brandes (RP)

Institute for Cardiovascular Physiology, Goethe-University, Theodor-Stern Kai 7, Frankfurt, Frankfurt am Main, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site RheinMain, Theodor-Stern Kai 7, Frankfurt, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH